Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.

Feagan BG, Hanauer SB, Coteur G, Schreiber S. Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol. Aliment Pharmacol Ther. 2011 May; 33(10):1143-51.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Crohn Disease
Humans
Immunoglobulin Fab Fragments
Injections, Subcutaneous
Polyethylene Glycols
Quality of Life
Severity of Illness Index
Sickness Impact Profile
Statistics as Topic
Treatment Outcome
Tumor Necrosis Factor-alpha

authors with profiles

Stephen B. Hanauer